Brief: Spectrum Pharmaceuticals Announces New Strategic Investment By Hanmi Pharmaceutical
04/01/2022 12:03
Jan 4 (Reuters) - Spectrum Pharmaceuticals Inc SPPI.O :
* SPECTRUM PHARMACEUTICALS ANNOUNCES NEW STRATEGIC
INVESTMENT BY
HANMI PHARMACEUTICAL
* SPECTRUM PHARMACEUTICALS - $20 MILLION EQUITY INVESTMENT
BY
HANMI PHARMACEUTICAL ALONG WITH REVISIONS TO LICENSING
AGREEMENTS FOR ROLONTIS AND POZIOTINIB
* SPECTRUM PHARMACEUTICALS - HANMI ENTERED INTO A $20
MILLION
EQUITY PURCHASE AGREEMENT THAT WILL BE PRICED AT $1.60 PER SHARE
Source text for Eikon: ID:nBw8ftcyWa
Further company coverage: SPPI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary